Categories: India

BRIEF-Natera Inc Says IMvigor011 Trial Achieves 41% Improvement In Overall Survival

Oct 20 (Reuters) – Natera Inc: * NATERA INC: SUCCESSFUL IMVIGOR011 TRIAL ACHIEVES 41% IMPROVEMENT IN OVERALL SURVIVAL FOR BLADDER CANCER PATIENTS Source text: Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

BRIEF-China Resources Land Posts October Gross Contracted Sales RMB15.70 Billion

Nov 12 (Reuters) - China Resources Land Limited : * OCTOBER GROSS CONTRACTED SALES RMB15.70…

6 minutes ago

Infantino plays down security fears over U17 World Cup, refuses questions on presidency

VIDEO SHOWS: FIFA PRESIDENT GIANNI INFANTINO TOURING FACILITIES FOR THE U17 WORLD CUP / SOUNDBITES…

7 minutes ago

Nvidia CEO Jensen Huang steps down

Nov 12 (Reuters) - Nvidia CEO Jensen Huang is stepping down, leaving the AI industry…

10 minutes ago

Nvidia CEO Jensen Huang steps down

Nov 12 (Reuters) - Nvidia CEO Jensen Huang is stepping down, leaving the AI industry…

11 minutes ago

BRIEF-DIA Completes Sale Of 100% Of DIA Argentina To Dorinka

Nov 12 (Reuters) - Distribuidora Internacional de Alimentacion SA: * COMPLETES SALE OF 100% OF…

16 minutes ago